Renal Cell Carcinoma, Gp200-MR6 antibody
-
- Target
- Renal Cell Carcinoma, Gp200-MR6
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- Un-conjugated
-
Application
- Flow Cytometry (FACS), ELISA
- Cross-Reactivity
- Human
- Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
- Characteristics
- Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY-75, Podocalyxin)
- Purification
- Purified by Protein G affinity chromatography.
- Immunogen
- E. coli-derived rhDEC-205
- Clone
- 9H176
- Isotype
- IgG1
-
-
- Application Notes
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with 200 μL sterile PBS.
- Buffer
- Supplied as a lyophilized powder from PBS, 5 % trehalose.
- Storage
- -20 °C
- Storage Comment
- -20°C
-
- Target
- Renal Cell Carcinoma, Gp200-MR6
-